BE708557A - - Google Patents

Info

Publication number
BE708557A
BE708557A BE708557DA BE708557A BE 708557 A BE708557 A BE 708557A BE 708557D A BE708557D A BE 708557DA BE 708557 A BE708557 A BE 708557A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE708557A publication Critical patent/BE708557A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE708557D 1966-12-28 1967-12-27 BE708557A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB57963/66A GB1138405A (en) 1966-12-28 1966-12-28 Morpholine derivatives
GB5796367 1966-12-28

Publications (1)

Publication Number Publication Date
BE708557A true BE708557A (cg-RX-API-DMAC7.html) 1968-06-27

Family

ID=26267707

Family Applications (1)

Application Number Title Priority Date Filing Date
BE708557D BE708557A (cg-RX-API-DMAC7.html) 1966-12-28 1967-12-27

Country Status (7)

Country Link
US (1) US3714161A (cg-RX-API-DMAC7.html)
BE (1) BE708557A (cg-RX-API-DMAC7.html)
CH (1) CH504452A (cg-RX-API-DMAC7.html)
DE (1) DE1695295C2 (cg-RX-API-DMAC7.html)
FR (2) FR1571341A (cg-RX-API-DMAC7.html)
GB (1) GB1138405A (cg-RX-API-DMAC7.html)
NL (1) NL157303B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4317141A1 (en) 2022-08-04 2024-02-07 Curia Spain S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959273A (en) * 1966-12-28 1976-05-25 Imperial Chemical Industries Limited Morpholine derivatives
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la
BE759013R (fr) * 1969-11-17 1971-05-17 Ici Ltd Derives de la
US3806595A (en) * 1971-08-09 1974-04-23 Ici Ltd Method of producing anorexia
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
US4109088A (en) * 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
DE2530860C2 (de) * 1975-07-10 1987-01-15 Yoshitomi Pharmaceutical Industries, Ltd., Osaka 2-[2-(2-Thenyl)-phenoxymethyl]-morpholin-Derivate
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4241059A (en) * 1979-12-17 1980-12-23 E. R. Squibb & Sons, Inc. 6-[(Aryloxy)methyl]-2-morpholinemethanol derivatives and use thereof
FR2534915B1 (fr) * 1982-10-26 1985-10-25 Lafon Labor Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2612926B1 (fr) * 1987-03-24 1989-06-09 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US5521180A (en) * 1993-02-10 1996-05-28 Yamanouchi Pharmaceutical Co., Ltd. Morpholine derivative
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
JP4185154B2 (ja) * 2004-04-30 2008-11-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 中枢神経系障害治療用の置換モルホリン化合物
DE602007011793D1 (de) 2006-10-18 2011-02-17 Pfizer Prod Inc Biaryl-ether-harnstoffverbindungen
US20100069390A1 (en) 2008-09-05 2010-03-18 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (ADHD)
EP2558437B1 (en) 2010-04-12 2015-08-05 Supernus Pharmaceuticals, Inc. Methods for producing viloxazine salts and novel polymorphs thereof
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
ES2950875T3 (es) 2012-02-08 2023-10-16 Supernus Pharmaceuticals Inc Formulaciones de liberación modificada de viloxazina
WO2025219523A1 (en) 2024-04-19 2025-10-23 Cambrex Profarmaco Milano S.R.L. "intermediates and processes for the preparation of viloxazine"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH356451A (de) * 1957-04-05 1961-08-31 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinverbindungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4317141A1 (en) 2022-08-04 2024-02-07 Curia Spain S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives
WO2024028423A1 (en) 2022-08-04 2024-02-08 Curia Spain, S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives

Also Published As

Publication number Publication date
FR7557M (cg-RX-API-DMAC7.html) 1969-12-29
GB1138405A (en) 1969-01-01
FR1571341A (cg-RX-API-DMAC7.html) 1969-06-20
DE1695295C2 (de) 1984-01-05
NL6717719A (cg-RX-API-DMAC7.html) 1968-07-01
US3714161A (en) 1973-01-30
CH504452A (de) 1971-03-15
NL157303B (nl) 1978-07-17
DE1695295A1 (de) 1975-03-20

Similar Documents

Publication Publication Date Title
FR1571341A (cg-RX-API-DMAC7.html)
AT281852B (cg-RX-API-DMAC7.html)
AU612166A (cg-RX-API-DMAC7.html)
AU6597365A (cg-RX-API-DMAC7.html)
AU6703465A (cg-RX-API-DMAC7.html)
BE626310A (cg-RX-API-DMAC7.html)
BE694155A (cg-RX-API-DMAC7.html)
BE674882A (cg-RX-API-DMAC7.html)
BE674792A (cg-RX-API-DMAC7.html)
BE675139A (cg-RX-API-DMAC7.html)
BE674777A (cg-RX-API-DMAC7.html)
BE674713A (cg-RX-API-DMAC7.html)
BE673316A (cg-RX-API-DMAC7.html)
BE694612A (cg-RX-API-DMAC7.html)
BE675173A (cg-RX-API-DMAC7.html)
BE666282A (cg-RX-API-DMAC7.html)
BE694367A (cg-RX-API-DMAC7.html)
BE694209A (cg-RX-API-DMAC7.html)
BE662818A (cg-RX-API-DMAC7.html)
BE654686A (cg-RX-API-DMAC7.html)
BE637138A (cg-RX-API-DMAC7.html)
BE694163A (cg-RX-API-DMAC7.html)
BE694158A (cg-RX-API-DMAC7.html)
BE624223A (cg-RX-API-DMAC7.html)
BE618801A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: IMPERIAL CHEMICAL INDUSTRIES LTD

Effective date: 19871227